Parallax Volatility Advisers
DMII

Parallax Volatility Advisers’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Parallax Volatility Advisers’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-133,647
Closed -$1.34M – 1768
2026
Q1 		$1.34M Buy
+133,647
New +$1.33M ﹤0.01% 870

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Parallax Volatility Advisers's DMII Position: Q2 2026 in Review

Parallax Volatility Advisers sold out of Drugs Made In America Acquisition II Corp (DMII) in Q2 2026, closing a stake of 133,647 shares — an estimated $1.34M sold.

Parallax Volatility Advisers first reported a position in DMII in Q1 2026 and held it in 1 quarter. The position peaked at $1.34M in Q1 2026. 69 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Parallax Volatility Advisers reported no remaining Drugs Made In America Acquisition II Corp position as of Q2 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 133,647 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $1.34M.
  • Parallax Volatility Advisers first reported a position in Drugs Made In America Acquisition II Corp in Q1 2026 and held it in 1 quarter.
  • Parallax Volatility Advisers's Drugs Made In America Acquisition II Corp position peaked at $1.34M in Q1 2026.
  • 69 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.